chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax;fever of 102.6 & fine red rash lasting 2 days;rash & fever appearing approx 2 wk p/ vax
Information has been received from a physician concerning a 12 month old white male pt who on 22Jul2003 was vaccinated in the right thigh with a first dose of varicella virus vaccine live. Concomitant therapy was also administered on 22Jul2003 included a dose of Streptococcus pneumoniae vaccine (Prevnar) and a first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) in the left thigh. On 15Aug2003 (also reported by physician as 17Aug2003 the pt developed a fever which continued to 17Aug2003. On 15Aug2003 he also developed a lack of balance, falling down, and red papular eruptions on trunk. It was noted that on 20Aug2003 the pt became slightly ataxic. The physician reported that as of 27Aug2003 the pt was seen at the physician's office and was reported to have a mild ataxic gait (also reported as still has some ataxia). It was noted that the adverse event did not abate. The physician reported that he did not have a lot of time to offer information because he was seeing patients. There was no treatment required for the adverse event. There was no product quality complaint involved. Follow up information from the physician reported that he had referred the pt to a neurologist at a children's medical center, and the pt was seen on 28Aug2003. On an unspecified date in approximately Aug 2003 the following diagnostic tests were performed.: computed axial tomography (CAT) scan of the head was normal, West Nile serology was negative, Epstein-Barr Virus serology was negative, HV17 and VMA on his urine was negative. The physician reported a "clinical recovery over 3-4 days after neurology consult". The physician reported that the pt had no adverse events following prior vaccinations. Additionally he reported that "handouts on varicella virus vaccine live and  measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) were given to mom". Unspecified medical attention was sought. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a adult female patient who received SHINGRIX for prophylaxis. In October 2018, the patient received the 1st dose of SHINGRIX (intramuscular). In October 2018, 1 day after receiving SHINGRIX, the patient experienced pain in arm, joint pain and shoulder pain. On an unknown date, the outcome of the pain in arm, joint pain and shoulder pain were not recovered/not resolved. It was unknown if the reporter considered the pain in arm, joint pain and shoulder pain to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The case was reported by the daughter who reported for her mother. The patient received SHINGRIX in the right arm. The reporter reported that she experienced very intense arm and joint and shoulder pain. The pain was not at the injection site but on her right arm which was the same arm that she received the injection. The reporter believed that she has had the pain which started a day or two since she received the injection in October 2018. The reporter could not recall her mother's physician name. The reporter consented to follow up.
Sharp pain or knot in left arm, fever since I got the flu shot. Told Doctor about it and my husband. Still pain
A nurse reported that a 28-year-old male had a decreased response to the hepatitis B vaccine recombinant (Engerix-B) immunization series. The pt's medical history, concurrent conditions and concurrent medications were unknown. The pt received injections of Engerix-B on 03/26/2002 (lot ENG5257A4), 05/21/2002 (lot ENG5263A4) and 11/25/2002 (lot ENG5291A4). 87 days after his 3rd injection of Engerix-B, on 02/20/2003, an unspecified titer was 7. Comment: the reporter indicated that 4 additional subjects did not achieve protective antibody titers following immunization with Engerix-B. Please see reports A0398883A, A0400568A, A0400570A and A0400571A.
Numbness and tingling around mouth and  of fingers.   (also had expected myalgia)
Pain radiating out from injection site in all directions. Muscle aches and weakness in arms, legs torso and neck. Started the day following injection.
Pt was given wrong dose of Pfizer Bivalent, given 0.3ml. Should have been given 0.2ml
The child received two Hib vaccines. He received Pedvax HIB and Pentacel (Dtap, Hib, and IPV). Staff has been educated. Dr. has been notified. Employee with Regulatory Authority has been called. Dr. called and spoke with the childs mom to let her know of any signs and symptoms to watch for since the child received 2 doses of hib today.
RECEIVED THE VACCINE Friday at work. Normal arm soreness after. That night started having severe arm pain with pain into chest and left arm pit as well as itching. Woke up Saturday AM with rash across body worse on both arms, large amount of swelling/redness/pain around the size of a palm at injection site. Continued severe pain in arm/armpit into Sunday. As of Monday arm is still swollen. Took Benedryl 3X to get rash to go away, also took Tylenol 500MG to help with pain discomfort. Extreme fatigue/vivid dreams
Patient received a Moderna vaccine dose  on 4/23/21 after having previously received a Pfizer dose on 3/10/21. Although the patient listed on the consent form that she previously received a Pfizer dose (location not listed), the pharmacist missed seeing it on the consent form until after having already vaccinated the patient. The pharmacist did verbally tell the patient that she was receiving the Moderna vaccine previous to giving it as he dose to all patients. The patient affirmed yes. Patient explained afterwards that she was unable to get back to original vaccination site.
When my son was receiving his ?first? vaccination, the plunger was not pressed, and no medication was administered.
Nausea, body aches lasted 1 night. Headache  started at back of head and neck covering whole head. Head tightening lasting for 5 days now
Vasovagal response (dizzy, heart racing).  Later experienced mild nausea/queasiness, "spaciness" and mild heart pressure or tightness.. Nurse at fairgrounds assessed patient and advised patient to lay back with feet up.  Patient was provided water and encouraged to rest and slowly sit up when she was ready to drive - a period of 15-20 minutes.  Patient drove to a nearby mall to get some food and rest further before driving home.  (Patient had already had breakfast.)  Patient continued to experience mild nausea/queasiness and "spaciness" as well as mild heart pressure or "tightness" through the following day.
Influenza shot provided by clinic on 1/10/2013. I am reporting an adverse reaction and potentially life changing health problem which I believe was caused by a recent influenza shot. I am a 51 year old male who was in excellent health until receiving a flu shot at a local pharmacy on January 10th 2013. I had never received a prior flu shot in my life before and because of all the media hype saying that this was going to a bad flu season decided to get one. Soon after I developed pain and swelling on my toes. My primary care doctor was unable to see me for several months so went to urgent care that day January 22nd. They took photos of my feet, blood work and sent me to hospital to have a blood bacterial culture done. Both the urgent care and hospital blood lab results came in normal. I was then recommended to see a dermatologist by my primary care doctor which I did and had 2 more sets of blood work done to rule out HIV, Diabetes, Hepatitis, and a anti - streptolysin test. Blood tests were taken 1/31 and 2/7 which both came back normal. The dermatologist diagnosed me with Vasculitis. I then was recommended by my primary care doctor to have an ultra sound done on my legs which was done in a hospital setting on March 4th. Results have come back normal. Something in my immune system changed after receiving the influenza vaccine on January 10th to cause vasculitis. After taking a course of Prednisone to reduce inflammation in March I thought the condition would subside but recently have had extreme swelling in my feet again along with evidence of vasculitis appearing in my finger tips as well. I don't know how someone with a healthy history comes down with disease all of a sudden but there is a strong correlation in my case between the flu shot and the sudden onset of Vasculitis. At this point I am waiting to see a Rheumatologist on April 18th to see if they can determine what has triggered this sudden auto immune disease.
Did not have an adverse event, patient was given a pediatric dose of Hep A instead of the adult dose
This is a spontaneous case, initially received from other health professional on 30-Jan-2018, concerning a 54-year-old, adult, female patient. The patient's medical history and concomitant medications were not reported. It was reported that, on an unspecified date, storage temperature FLUCELVAX vaccine reached 0.18 degrees C, for about 45 minutes and there were four different excursions which are all exceeding 30 minutes range. On 30-Jan-2018, the patient was administered with FLUCELVAX QIV which undergone temperature excursion (route of administration: intramuscular, anatomical location: deltoid, batch number: 195215 and expiry date: 30-Apr-2018, dose: not reported). It was reported that, the patient had not experienced any adverse event after the vaccination and patient was not revaccinated. The reporter assessed this case as non-serious. Follow up received on 19-Feb-2018: The reporter confirmed that, the patient had not experienced any adverse event after the vaccination and patient was not revaccinated. The narrative was amended accordingly.
Hives all over body, no trouble breathing, treated with oral Cetirizine 10 mg.
Rash inside both elbows, and on back of legs. Left side is worse then right side. I had the shot on my left side. Very itchy and feels scaly. Slightly raised small red bumbs.
Upper left arm (injection site) patient expereinced discomfort, worsening erythema, cellulitis possibly secondary to vaccine.  Treatment given included: vancomycin 1gm and ciprofloxacin 500mg every 12hrs X 3day.
When arriving home felt weak with body aches which continued into the next day of bed rest with temp reaching 103.
Patient received both doses of Pfizer COVID vaccine on 1/11/21 and 2/22/21 which completed series.  Patient did not need Moderna COVID vaccine on 3/25/21.
1 day after getting vaccinated, patient developed 2 inch red rash at the injection site that was hard and tender to touch. Patient is taking zyrtec and applying ice to her thigh. She also developed fatigue and low grade temperature that improved.
Swelling, itchiness, pain at the injection site beginning on day 7. Hot to the touch. Red. Progressive expanding of red, hot area. "went from semicircle lump to big half dome".  Axillary lymphadenopathy on affected (L) side. Chills at night 01.19 into 01.20. Seeking medical care with PCP on 01.20.
A nurse reported that a 47 year old male received an injection of Typhoid, USP, Heat Phenol Inactivated, Hep-A and tetanus toxoid vaccines on 6/18/99, and subsequently, developed a "severe" injection site reaction at the site of the Typhoid injection characterized by redness and swelling. The pt was unable to use that arm for 1 week; he recovered without treatment.
WITHIN 24 HR OF VACCINES, PT GOT RAISED RASH ON BOTH ARMS. RX KEFLEX 250MG TID FOR 1 WK. CLARITIN RX, BENADRYL HS PRN.RETURN IF NOT IMPROVED.
Fever; Chills; Shakes; A spontaneous report was received from a consumer concerning a male patient who received Moderna (mRNA-1273) and experienced fever, chills and shakes.    The patient's medical history was not provided. Concomitant product use was not provided/unknown by the reporter.   The patient received their first of two planned doses of mRNA-1273 (Lot number unknown) on an unknown date intramuscularly for prophylaxis of COVID-19 infection.   The patient's wife called (04 Jan 2021) to report that her husband had received the covid-19 shot on Saturday and still has fever, chills, and shakes that they have been able to control with Ibuprofen.   Treatment for the event included ibuprofen.    Action taken with mRNA-1273 in response to the events was unknown.   The outcome of the events fever, chills, and shakes were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Headache; Muscle pain; Chills; Joint pain; Fever of 100.2; Swollen lymph nodes; Threw up; This is a spontaneous report from a contactable nurse, the patient. This male patient of unknown age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), single dose via an unspecified route of administration on 15Jan2021 for COVID-19 vaccination. Relevant medical history was unknown. Concomitant medications were unknown. The patient did not receive any other vaccine within 4 weeks prior to the vaccine. On 16Jan2021, the patient had a headache, muscle pain, chills, joint pain, fever of 100.2, swollen lymph nodes and threwup. The outcome of the events headache, muscle pain, chills, joint pain, fever of 100.2, swollen lymph nodes and threw up was unknown.   Information on the lot/batch number has been requested.
Cerebrovascular thrombus, with partial loss of sight. Numbness of the left arm
p/vax pt out of country; began to lose major motor milestones; stopped cruising; stopped bearing weight; lost ability to sit-up; could not roll over; difficulty swallowing; areflexia; poor head control; irritable; tx: IV Immunoglobulin
First pregnancy.  Due date was anticipated for June.    Still birth death on May 10, 2018 (at 9 months).
Inflamed area noted to left arm that is warm to touch, tender, and lumpy; Inflamed area noted to left arm that is warm to touch, tender, and lumpy; Inflamed area noted to left arm that is warm to touch, tender, and lumpy; Inflamed area noted to left arm that is warm to touch, tender, and lumpy; 100.0 temp; Possible cellulitis; It appears that the injection was given too low that muscle may have been missed; May not have received the full dose of the Moderna vaccine; A spontaneous report  was received from a nurse, concerning a 91-year-old male patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced inflamed area noted to left arm that is warm to touch, tender, and lumpy, 100.0 temp, may not have received the full dose of the Moderna vaccine, it appears that the injection was given too low that muscle may have been missed, and possible cellulitis.   The patient's medical history was not provided. Concomitant medications were not reported.   On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Batch number: 039K208) intramuscularly in the left arm for the prophylaxis of COVID-19 infection. On 26 Jan 2021, at the time of the onset of the events, the patient received their second of two planned doses of mRNA-1273 (Batch number: 012M20A) intramuscularly in the left deltoid for the prophylaxis of COVID-19 infection.   On 26 Jan 2021, the patient may not have received the full dose of the Moderna vaccine as it appeared that the injection was given too low that muscle may have been missed.    On 28 Jan 2021, the patient experienced an inflamed area to the left arm, that was warm to touch, tender, and lumpy. The patient also had fever of 100.0 Fahrenheit (F). He was being evaluated for concerns of possible cellulitis Treatment for the events included paracetamol and diphenhydramine.   The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.  The outcome of events, inflamed area noted to left arm that is warm to touch, tender, and lumpy, 100.0 temp, may not have received the full dose of the Moderna vaccine, and possible cellulitis, were considered unknown. The events, it appears that the injection was given too low that muscle may have been missed and may not have received the full dose of the Moderna vaccine, were considered resolved on 26 Jan 2021.; Reporter's Comments: This case concerns a 91-year-old, White, male, who experienced a Product administration error, Incorrect dose administered, and non-serious unexpected event of injection site cellulitis, injection site warmth, and non-serious expected events of injection site swelling, injection site pain, and pyrexia. There were no reported AEs associated with this case of a Product administration error and incorrect dose administered.  The events occurred  2 days after mRNA-1273 (Lot# 039k208). Treatment included Tylenol and Benadryl. Based on temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Additional information has been requested.
Headaches, myalgias, nausea, loose stools, dizziness, SOB brief left lateral chest pain. Patient states she had her usual dyspnea on exertion only when running fast (& previous since BASIC of climbing moderate stairs). Pt had chills, sweats, loose green diarrhea 3 times, myalgias, dizziness including transient spinning sensation.
MODERNA COVID-19 VACCINA EUA Shortly after injection, became bloated but was able to eat lunch & light dinner later. About 1:30 am on 2/24/21, I became nauseous, followed shortly after by vomiting until everything, including my lunch came out. That lasted until 5am. About 4:30 projectile diarrhea started for another 3 hours. About 8 am, diarrhea continued but it wasn't as bad and I still has nausea. The lessened symptoms lasted until about noon on 2/24. I was extremely weak and very dizzy. My normal temp is 97.2 but I had a fever that climbed to 99.9 by 3 pm and stayed at that level until it broke during the night. During the day I could only drink water. I tried a bite of banana but started feeling nauseous again. Today, 2/25, I was able to drink water as usual and have 2 light meals. I am gaining my strength back.
Patient was accidentally given higher dose than recommended for pediatric patients. Patient's mother reports no symptoms the day or post vaccination.
The same day I received the shot- that night my arm started to feel very sore and developed a rock-hard bump. The next day I was extremely tired and not feeling well. The evening after the shot I felt feverish and my temperature reached 102 (and my ?normal? temp is usually ~97.5). I felt achey for a couple days after and stayed home all weekend feeling tired. My arm felt better about 3 days after the injection.
Patient presented to ER with severe unrelenting chest pain beginning abruptly 4 days after receiving first dose of Pfizer COVID19 vaccine. He was diagnosed at the ER with pericarditis and discharged with ibuprofen. Chest pain has gradually improved over past 6 days though is still intermittently present.
A WEEK AFTER VACCINATION PATIENT DESCRIBED HEADACHE, FATIGUE THAT LASTED SEVERAL WEEKS.  ADVISED TO SEEK MEDICAL FOLLOW-UP.  PATIENT IS SPANISH SPEAKING AND DOES NOT LIVE IN TEXAS FULL TIME.
Swollen lymph nodes in left underarm; Dose 1: 05Mar2021Dose 2: 27Sep2021; This is a spontaneous report from a non-contactable consumer, the patient. A 53-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2589) via an unspecified route of administration in the left arm on 27Sep2021 at 17:30 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's concomitant medications were reported as not applicable. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 05Mar2021 at 12:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. On 30Sep2021 at 06:00, the patient experienced swollen lymph nodes in left underarm. The adverse event did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph nodes in left underarm was resolving at the time of this report.   No follow-up attempts are possible. No further information is expected.
This case was reported by a physician and described the occurrence of swelling injection site in a 58-year-old female subject who was vaccinated with Flu vaccine (manufacturer unspecified). On 28 March 2011 at 12:00 the subject received unspecified dose of Flu vaccine (.5 cc, unknown route, right arm). On 29 March 2011, 1 day after vaccination with Flu vaccine, the subject experienced swelling injection site and injection site tenderness. At the time of reporting the events were unresolved. The physician was asking for recommendations to treat the site of the vaccine and provided no further information.
The vaccines ordered by provider were MMRV, IPV, DTaP and Hep A. This patient insurance was a commercial insurance and VFC vaccines were used in error.
Pt had vertigo for about 5 days following vaccine administration,  Pt took OTC meclizine which worked to combat the symptoms. Pt reported he has experienced vertigo during active infection in the past more than once.
Rash, redness of skin, itchiness, bumps.  Minor irritation the first evening.  Very bad the next night, I have pictures.  Minor rash and irritation the following two evenings.
swollen lips four days after each vaccination.  Second time it has not resolved as of today.  Have scheduled with allergist.
full body rash, could not breath O2 saturation was below 80, fever, body ache's  I was in the hospital for over 2 weeks including ICU with various tests
covid vaccine breakthrough case  dose 1  1/20/21 Pfizer  EL3249 dose 2  5/9/21  Pfizer  EL9265
pt recv vax & w/in 1min p/inject completed both legs (upper, lower & feet) became flushed bright pink & face became pale;no resp distress;HR 140 & regular w/in 5min leg flush resolved;scattered petechiae;
Left deltoid - inject site erythema, induration, mild pain. About 5 to 6 cm large, warm. No significant systemic reaction.
Rash all over arm; injection site is itchy; muscle soreness; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash all over arm), VACCINATION SITE PRURITUS (injection site is itchy) and MYALGIA (muscle soreness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced MYALGIA (muscle soreness). On 02-Feb-2021, the patient experienced RASH (Rash all over arm) and VACCINATION SITE PRURITUS (injection site is itchy). On 02-Feb-2021, MYALGIA (muscle soreness) had resolved. At the time of the report, RASH (Rash all over arm) and VACCINATION SITE PRURITUS (injection site is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.